�山ǿ�� News - ALS

New NPRC Reading Lists!

webfull — Fri, 06 Oct 2023 16:43:49 +0000

The Neuro-Patient Resource has created reading lists for each of the Neuro's outpatient clinics. Come borrow the books in room 354!

Download the PDF version of a reading list below:

Reading list about Amyotrophic lateral sclerosis

Reading list about Brain tumours

Published: 6 October 2023

September 2023 - New books available at the NPRC

webfull — Thu, 28 Sep 2023 17:57:18 +0000

Come visit us and borrow the books below today from room 354 at The Neuro:

Être du monde by Maryse Rouy
Voir la mer by Ruth Fitzmaurice
Epilepsies de l'enfant, de l'adolescent et de l'adulte : de la physiopathologie à la prise en charge by Sophie Dupont
Les Épilepsies N. éd. by Nathalie Tordjman
Épilepsie et psychiatrie by Pierre Thomas & Arnaud Biraben
L'Après-cancer : tout un programme ! by Philippe Gourdin & Gersande Bargine

Published: 28 September 2023

Books to highlight Stroke Awareness Month and ALS Awareness Month

webfull — Tue, 20 Jun 2023 14:38:56 +0000

We selected books from our collection to highlight Stroke Awareness Month and ALS Awareness Month, both happening in June.

We also have free resources that you can get at the Neuro-Patient Resource Centre (room 354).

In addition, our website contains information that is freely accessible:

Our online stroke resources: Stroke (Cerebrovascular accident)

Published: 20 June 2023

Tony Proudfoot’s legacy lives on

webfull — Mon, 28 Jun 2021 16:01:13 +0000

Maria Gobbo is the latest recipient of the ALS fellowship named in his honour

In 2010, former Montreal Alouette and �山ǿ�� physical education instructor Tony Proudfoot passed away from ALS. Ten years later, his legacy lives on in a fund that helps train and support the next generation of leaders fighting this disease.

Published: 28 June 2021

Multiple ALS projects at The Neuro awarded funding

webfull — Mon, 15 Feb 2021 15:29:35 +0000

Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease

Researchers at The Neuro (Montreal Neurological Institute-Hospital) make up a large part of eight projects funded by ALS Canada and the Brain Canada Foundation as part of their 2020 Discovery Grant Program, which brings together multidisciplinary research teams with expertise in various areas of ALS and neurodegenerative diseases to investigate critical areas of disease processes and clinical care.

Published: 15 February 2021

Improving research with more effective antibodies

webfull — Tue, 15 Oct 2019 16:55:16 +0000

Scientists demonstrate flaws in protein detection tools, and outline a solution

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly.

Antibodies are used in laboratories and clinics to study proteins, which are the biomolecules that translate information from an organism’s genes into the structure, function, and regulation of its tissues and organs. Genetic mutations can cause protein imbalances or malfunctions, leading to human disease.

Published: 15 October 2019

ALS Quebec launches Taking Care, a virtual learning environment for caregivers

webfull — Thu, 08 Nov 2018 15:35:13 +0000

Montreal, Thursday, November 8, 2018 – With the financial support of L’Appui national pour les proches aidants d’aînés and the collaboration of �山ǿ��’s Steinberg Centre for Simulation and Interactive Learning (SCSIL), the Amyotrophic Lateral Sclerosis (ALS) Society of Quebec is proud to launch a virtual education program Taking Care, intended for those caring for someone living with ALS.

On-demand virtual support

Published: 8 November 2018

The Neuro and Thermo Fisher Scientific Partner to Fight Neurodegenerative Disease

webfull — Mon, 05 Mar 2018 16:07:47 +0000

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Published: 5 March 2018

The MNI forms promising Open Science partnership with Takeda

webfull — Mon, 04 Dec 2017 19:37:18 +0000

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Published: 4 December 2017

Busy week for ALS research and awareness

webfull — Wed, 13 Sep 2017 21:32:12 +0000

Research symposium, public education event and ALS walk planned

Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.

Published: 13 September 2017